This is the branch of medicine concerned with the treatment of disease and in particular the Mesothelioma Research Foundation of America is focused on the treatment of mesothelioma cancer. This includes supporting research on a medicine or therapy that treats or cures this cancer disease or relieves its pain.

A therapeutic treatment or therapeutic cure is applied after the mesothelioma cancer problem has already started.

This Foundation continues its research in Veglin as a therapeutic treatment that treats the mesothelioma disease with good results that bring us hope in that it may lead to a cure. Still, some treatments often ameliorate a problem only for as long as the treatment is continued, especially in chronic diseases. Chemotherapy is an example of a treatment for some types of cancer. While chemotherapy may cause a cure in some patient cases, it can not in all cases be a cure for all cancers. Some conditions are said to be untreatable when nothing can be done to stop or improve a medical condition other than make efforts to bring the patient more comfort. Sometimes, an untreatable condition may naturally or miraculously resolve itself; while others will not.

The mission of this Foundation is the discovery of a mesothelioma cancer cure; a subset of treatments that reverse the cancer illness completely or end its medical problems permanently.

Mesothelioma cancer cure research continues with developing new compounds and treatments with a few listed below.

Development of Compounds and Treatments for Clinical Trials

  • VEGF inhibitor VEGF-Diphtheria toxin
  • allogeneic tumor vaccine
  • Amifostine
  • Azacitidine
  • Bevacizumab
  • CBP501
  • Celecoxib
  • Cisplatin
  • Disatinib
  • Flovopiridol
  • FR901228 Depsipeptide
  • Gemcitabine
  • gene therapy
  • IHOC Cisplatin
  • Intensity Modulated Radiotherapy (IMRT)
  • Liposomal Taxol
  • metronomic oral Cyclophosphmide
  • Oxaliplatin
  • Paclitaxol
  • Pemetrexed
  • Sodium Thiosulfate cytoprotection
  • Sorafenib
  • SSI (dsFv) - PE38 immunotoxin
  • Sunitinib plus radiation
  • Temozolomide

Our Oncologists and the Foundation would be glad to address your questions about new compounds and treatments, for FREE. Ask HERE!